Pancreatic Tumors Build Immune Shields via Clotting Pathway

Researchers at the Icahn School of Medicine at Mount Sinai have discovered that small clusters of pancreatic cancer cells can form localized immune‑protective niches within tumors, effectively shielding the cancer from immune attack. The study, published in a peer‑reviewed journal, shows that these micro‑environments recruit and activate immune‑suppressive cells, creating a barrier that limits the reach of circulating immune cells.

The findings highlight a previously underappreciated mechanism by which pancreatic tumors evade the immune system, a key challenge in treating this aggressive cancer. By mapping the spatial distribution of immune cells and tumor subpopulations, the team identified specific signaling pathways that sustain the protective niches. Targeting these pathways could disrupt the shield and enhance the efficacy of existing immunotherapies.

If successfully translated into clinical interventions, the research could improve outcomes for patients with pancreatic cancer, one of the deadliest malignancies. The study opens new avenues for developing combination therapies that dismantle the immune‑protective micro‑environments and restore the immune system’s ability to recognize and destroy tumor cells.